Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms

Br J Haematol. 2021 Sep;194(6):1010-1015. doi: 10.1111/bjh.17644. Epub 2021 Jun 24.

Onima Chowdhury^{1

2

3}, Hannah Bruguier³, Garry Mallett³, Nikolaos Sousos^{1

2

3}, Kirsty Crozier³, Caroline Allman³, David Eyre^{4

5}, Sheila Lumley^{5

6}, Marie Strickland^{1

2}, Christina S Karali^{1

2}, Lauren Murphy^{1

2}, Alex Sternberg³, Katie Jeffery⁵, Adam J Mead^{1

2

3}, Andy Peniket³, Bethan Psaila^{1

2

3}

¹ MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
² National Institute of Health Research Oxford Biomedical Research Centre, Oxford, UK.
³ Department of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
⁴ Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK.
⁵ Department of Microbiology, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
⁶ Nuffield Department of Medicine, University of Oxford, Oxford, UK.

No abstract available

Publication types